Doctors do not typically use a cystoscopy to detect or diagnose prostate cancer, but it may reveal abnormalities in the prostate or signs of cancer in the bladder and other areas of the urinary tract.
Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...
These differences remained significant beyond the initial 90 days, indicating durable diagnostic sensitivity and facilitating earlier, risk-appropriate treatment decisions, which supports broader ...